PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.\', \'University Hospital of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.\', \'Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.\', \'Central Institute for Medical and Chemical Laboratory Diagnosis, University Hospital Innsbruck, Innsbruck, Austria.\', \'Munich Leukemia Laboratory (MLL), Munich, Germany.\', \'Department of Internal Medicine, Hospital Kufstein, Kufstein, Austria.\', \'Department of Internal Medicine, Hospital Zams, Zams, Austria.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.684014
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34194438
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all